The effect of treating patients with anaemia in diabetic nephropathy to different target haemoglobin levels with epoetin beta
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2009
At a glance
- Drugs Epoetin beta (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms ESA-2
- 09 Feb 2009 Status is now discontinued, as reported by ISRCTN: Current Controlled Trials.
- 25 Apr 2007 New trial record.